+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Coated Endotracheal Tube Market by Intubation, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 189 Pages
  • November 2021
  • Region: Global
  • Allied Market Research
  • ID: 5533804
The coated endotracheal tube market was valued at $126.13 million in 2020, and is projected to reach $237.99 million by 2030, growing at a CAGR of 6.5% from 2021 to 2030.



Endotracheal tube is a metal or plastic tube introduced in the trachea through the mouth or nose to confirm the adequate exchange of oxygen and carbon dioxide and maintains the patient’s airway. Coated endotracheal tube is a specific tube coated with antithrombotic agents to prevent coagulation or antibiotic agents such as polyvinyl chloride, silver, and various drugs to prevent the growth of bacteria on the surface of endotracheal tube. Endotracheal tube is inserted to trachea that needs to be replaced frequently, thus causing excessive discomfort in patients. Hence, to prevent frequent replacements, tubes are treated with antibacterial agents.

The major factor that drives the growth of the global coated endotracheal tube market is rise in number of surgical procedures due to increase in prevalence of chronic respiratory diseases such as cardiovascular diseases, respiratory diseases, diabetes, cancer, and other lung injuries. Moreover, alarming rise in prevalence of ventilator-associated pneumonia and surge in number of aged individuals, who are highly susceptible to chronic diseases boost the market growth. However, post-operative complications related to endotracheal intubation and lack of skill healthcare professionals hamper the market growth. On the contrary, the development of novel products by key vendors, majorly to prevent ventilator-associated pneumonia (VAP) condition by preventing bacterial colonization and biofilm formation on tube surface and untapped emerging economies, is anticipated to provide potential growth opportunities for the global market during the forecast period. The global coated endotracheal tube market is segmented into intubation, application, end user, and region. Depending on intubation, the market is bifurcated into orotracheal intubation and nasotracheal intubation.

By application, it is categorized into anesthesia, emergency medicine, and others. On the basis of end user, it is classified into hospital, clinics, and ambulatory surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.


KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global coated endotracheal tube market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the products and end users of coated endotracheal tube used across the globe.
  • Key market players and their strategies have been analysed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS


By Intubation

  • Orotracheal Intubation
  • Nasotracheal Intubation

By Application

  • Anesthesia
  • Emergency Medicine
  • Others

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Spain
  • Italy
  • UK
  • Rest of Europe
  • Asia-Pacific
  • Australia
  • Japan
  • India
  • China
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Bactiguard Holding AB
  • Avanos Medical
  • Hospiteknik Healthcare
  • Smiths Medical Plc.
  • Fuji Systems Corp.
  • N8 Medical, LLC
  • Sharklet Technologies, Inc.,
  • Medtronic
  • Teleflex Incorporated
  • Venner Medical

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. SECONDARY RESEARCH
1.4.2. PRIMARY RESEARCH
1.4.3. ANALYST TOOLS & MODELS
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. TOP INVESTMENT POCKETS
3.2.2. TOP WINNING STRATEGIES
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. DRIVERS
3.5.1.1. Rise in number of surgical procedures across the globe
3.5.1.2. Presence of large pool of geriatric population and related rise in chronic diseases
3.5.1.3. Advantages of coated endotracheal tubes
3.5.2. RESTRAINTS
3.5.2.1. Dearth of skilled professionals
3.5.2.2. Post-operative risks associated with laparoscopy surgeries
3.5.3. OPPORTUNITY
3.5.3.1. High growth potential in emerging economies
3.6. COVID-19 impact analysis on the coated endotracheal tube market
CHAPTER 4: COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION
4.1. Overview
4.1.1. MARKET SIZE AND FORECAST, BY INTUBATION
4.1. Orotracheal intubation
4.1.1. KEY MARKET TRENDS, GROWTH FACTORS, AND OPPORTUNITIES
4.1.2. MARKET SIZE AND FORECAST
4.1.3. MARKET ANALYSIS, BY COUNTRY
4.1. Nasotracheal intubation
4.1.1. KEY MARKET TRENDS, GROWTH FACTORS, AND OPPORTUNITIES
4.1.2. MARKET SIZE AND FORECAST
4.1.3. MARKET ANALYSIS, BY COUNTRY
CHAPTER 5: COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION
5.1. Overview
5.1.1. MARKET SIZE AND FORECAST, BY APPLICATION
5.2. Anesthesia
5.2.1. MARKET SIZE AND FORECAST
5.2.2. MARKET ANALYSIS, BY COUNTRY
5.3. Emergency medicine
5.3.1. MARKET SIZE AND FORECAST
5.3.2. MARKET ANALYSIS, BY COUNTRY
5.4. Other applications
5.4.1. MARKET SIZE AND FORECAST
5.4.2. MARKET ANALYSIS, BY COUNTRY
CHAPTER 6: COATED ENDOTRACHEAL TUBE MARKET, BY END USER
6.1. Overview
6.1.1. MARKET SIZE AND FORECAST, BY APPLICATION
6.2. Hospitals
6.2.1. MARKET SIZE AND FORECAST
6.2.2. MARKET ANALYSIS, BY COUNTRY
6.3. Clinics
6.3.1. MARKET SIZE AND FORECAST
6.3.2. MARKET ANALYSIS, BY COUNTRY
6.1. Ambulatory surgical centers (ASCs)
6.1.1. MARKET SIZE AND FORECAST
6.1.2. MARKET ANALYSIS, BY COUNTRY
CHAPTER 7: COATED ENDOTRACHEAL TUBE MARKET, BY REGION
7.1. Overview
7.1.1. MARKET SIZE AND FORECAST, BY REGION
7.2. North America
7.2.1. KEY TRENDS AND GROWTH OPPORTUNITIES
7.2.2. MARKET SIZE AND FORECAST, BY INTUBATION
7.2.3. MARKET SIZE AND FORECAST, BY APPLICATION
7.2.4. MARKET SIZE AND FORECAST, BY END USER
7.2.5. MARKET SIZE AND FORECAST, BY COUNTRY
7.2.5.1. U.S.
7.2.5.2. U.S. market size and forecast, by intubation
7.2.5.3. U.S. market size and forecast, by application
7.2.5.4. U.S. market size and forecast, by end user
7.2.5.5. Canada
7.2.5.6. Canada market size and forecast, by intubation
7.2.5.7. Canada market size and forecast, by application
7.2.5.8. Canada market size and forecast, by end user
7.2.5.9. Mexico
7.2.5.10. Mexico market size and forecast, by intubation
7.2.5.11. Mexico market size and forecast, by application
7.2.5.12. Mexico market size and forecast, by end user
7.3. Europe
7.3.1. KEY TRENDS AND GROWTH OPPORTUNITIES
7.3.2. MARKET SIZE AND FORECAST, BY INTUBATION
7.3.3. MARKET SIZE AND FORECAST, BY APPLICATION
7.3.4. MARKET SIZE AND FORECAST, BY END USER
7.3.5. MARKET SIZE AND FORECAST, BY COUNTRY
7.3.5.1. Germany
7.3.5.2. Germany market size and forecast, by intubation
7.3.5.3. Germany market size and forecast, by application
7.3.5.4. Germany market size and forecast, by end user
7.3.5.5. France
7.3.5.6. France market size and forecast, by intubation
7.3.5.7. France market size and forecast, by application
7.3.5.8. France market size and forecast, by end user
7.3.5.9. UK
7.3.5.10. UK market size and forecast, by intubation
7.3.5.11. UK market size and forecast, by application
7.3.5.12. UK market size and forecast, by end user
7.3.5.13. Italy
7.3.5.14. Italy market size and forecast, by intubation
7.3.5.15. Italy market size and forecast, by application
7.3.5.16. Italy market size and forecast, by end user
7.3.5.17. Spain
7.3.5.18. Spain market size and forecast, by intubation
7.3.5.19. Spain market size and forecast, by application
7.3.5.20. Spain market size and forecast, by end user
7.3.5.21. Rest of Europe
7.3.5.22. Rest of Europe market size and forecast, by intubation
7.3.5.23. Rest of Europe market size and forecast, by application
7.3.5.24. Rest of Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. KEY TRENDS AND GROWTH OPPORTUNITIES
7.4.2. MARKET SIZE AND FORECAST, BY INTUBATION
7.4.3. MARKET SIZE AND FORECAST, BY APPLICATION
7.4.4. MARKET SIZE AND FORECAST, BY END USER
7.4.5. MARKET SIZE AND FORECAST, BY COUNTRY
7.4.5.1. Japan
7.4.5.2. Japan market size and forecast, by intubation
7.4.5.3. Japan market size and forecast, by application
7.4.5.4. Japan market size and forecast, by end user
7.4.5.5. China
7.4.5.6. China market size and forecast, by intubation
7.4.5.7. China market size and forecast, by application
7.4.5.8. China market size and forecast, by end user
7.4.5.9. India
7.4.5.10. India market size and forecast, by intubation
7.4.5.11. India market size and forecast, by application
7.4.5.12. India market size and forecast, by end user
7.4.5.13. Australia
7.4.5.14. Australia market size and forecast, by intubation
7.4.5.15. Australia market size and forecast, by application
7.4.5.16. Australia market size and forecast, by end user
7.4.5.17. South Korea
7.4.5.18. South Korea market size and forecast, by intubation
7.4.5.19. South Korea market size and forecast, by application
7.4.5.20. South Korea market size and forecast, by end user
7.4.5.21. Rest of Asia-Pacific
7.4.5.22. Rest of Asia-Pacific market size and forecast, by intubation
7.4.5.23. Rest of Asia-Pacific market size and forecast, by application
7.4.5.24. Rest of Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. KEY TRENDS AND OPPORTUNITIES
7.5.2. MARKET SIZE AND FORECAST, BY INTUBATION
7.5.3. MARKET SIZE AND FORECAST, BY APPLICATION
7.5.4. MARKET SIZE AND FORECAST, BY END USER
7.5.5. MARKET SIZE AND FORECAST, BY COUNTRY
7.5.5.1. Brazil
7.5.5.2. Brazil market size and forecast, by intubation
7.5.5.3. Brazil market size and forecast, by application
7.5.5.4. Brazil market size and forecast, by end user
7.5.5.5. Saudi Arabia
7.5.5.6. Saudi Arabia market size and forecast, by intubation
7.5.5.7. Saudi Arabia market size and forecast, by application
7.5.5.8. Saudi Arabia market size and forecast, by end user
7.5.5.9. South Africa
7.5.5.10. South Africa market size and forecast, by intubation
7.5.5.11. South Africa market size and forecast, by application
7.5.5.12. South Africa market size and forecast, by end user
7.5.5.13. Rest of LAMEA
7.5.5.14. Rest of LAMEA market size and forecast, by intubation
7.5.5.15. Rest of LAMEA market size and forecast, by application
7.5.5.16. Rest of LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. Bactiguard Holding AB
8.1.1. COMPANY OVERVIEW
8.1.2. COMPANY SNAPSHOT
8.1.3. OPERATING BUSINESS SEGMENTS
8.1.4. PRODUCT PORTFOLIO
8.1.5. BUSINESS PERFORMANCE
8.2. Avanos Medical Inc.
8.2.1. COMPANY OVERVIEW
8.2.2. COMPANY SNAPSHOT
8.2.3. OPERATING BUSINESS SEGMENTS
8.2.4. PRODUCT PORTFOLIO
8.2.5. BUSINESS PERFORMANCE
8.3. Smiths Medical Plc.
8.3.1. COMPANY OVERVIEW
8.3.2. COMPANY SNAPSHOT
8.3.3. OPERATING BUSINESS SEGMENTS
8.3.4. PRODUCT PORTFOLIO
8.3.5. BUSINESS PERFORMANCE
8.4. Hospiteknik Healthcare
8.4.1. COMPANY OVERVIEW
8.4.2. COMPANY SNAPSHOT
8.4.3. OPERATING PRODUCT SEGMENTS
8.4.4. PRODUCT PORTFOLIO
8.5. MEDTRONIC PLC. (COVIDIEN)
8.5.1. COMPANY OVERVIEW
8.5.2. COMPANY SNAPSHOT
8.5.3. OPERATING BUSINESS SEGMENTS
8.5.4. PRODUCT PORTFOLIO
8.5.5. BUSINESS PERFORMANCE
8.6. N8 Medical, LLC
8.6.1. COMPANY OVERVIEW
8.6.2. COMPANY SNAPSHOT
8.6.3. OPERATING PRODUCT SEGMENTS
8.6.4. PRODUCT PORTFOLIO
8.6.5. KEY STRATEGIC MOVES AND DEVELOPMENTS
8.7. Sharklet Technologies, Inc.
8.7.1. COMPANY OVERVIEW
8.7.2. COMPANY SNAPSHOT
8.7.3. OPERATING PRODUCT SEGMENTS
8.7.4. PRODUCT PORTFOLIO
8.8. Fuji Systems Corporation
8.8.1. COMPANY OVERVIEW
8.8.2. COMPANY SNAPSHOT
8.8.3. OPERATING PRODUCT SEGMENTS
8.8.4. PRODUCT PORTFOLIO
8.9. Teleflex Incorporated
8.9.1. COMPANY OVERVIEW
8.9.2. COMPANY SNAPSHOT
8.9.3. OPERATING BUSINESS SEGMENTS
8.9.4. PRODUCT PORTFOLIO
8.9.5. BUSINESS PERFORMANCE
8.9.6. KEY STRATEGIC MOVES AND DEVELOPMENTS
8.10. Venner Medical GmbH
8.10.1. COMPANY OVERVIEW
8.10.2. COMPANY SNAPSHOT
8.10.3. OPERATING PRODUCT SEGMENTS
8.10.4. PRODUCT PORTFOLIO
List of Tables
TABLE 01. COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030($MILLION)
TABLE 02. COATED ENDOTRACHEAL TUBE MARKET FOR OROTRACHEAL INTUBATION, BY REGION, 2020–2030($MILLION)
TABLE 03. COATED ENDOTRACHEAL TUBE MARKET FOR NASOTRACHEAL INTUBATION, BY REGION, 2020–2030 ($MILLION)
TABLE 04. COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 05. COATED ENDOTRACHEAL TUBE MARKET FOR ANESTHESIA, BY REGION, 2020–2030($MILLION)
TABLE 06. COATED ENDOTRACHEAL TUBE MARKET FOR EMERGENCY MEDICINE, BY REGION, 2020–2030 ($MILLION)
TABLE 07. COATED ENDOTRACHEAL TUBE MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2030 ($MILLION)
TABLE 08. COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 09. COATED ENDOTRACHEAL TUBE MARKET FOR HOSPITALS, BY REGION, 2020–2030($MILLION)
TABLE 10. COATED ENDOTRACHEAL TUBE MARKET FOR CLINICS, BY REGION, 2020–2030 ($MILLION)
TABLE 11. COATED ENDOTRACHEAL TUBE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2030 ($MILLION)
TABLE 12. COATED ENDOTRACHEAL TUBE MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 13. NORTH AMERICA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 14. NORTH AMERICA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 15. NORTH AMERICA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 16. NORTH AMERICA COATED ENDOTRACHEAL TUBE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 17. U.S. COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 18. U.S. COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 19. U.S. COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 20. CANADA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 21. CANADA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 22. CANADA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 23. MEXICO COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 24. MEXICO COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 25. MEXICO COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 26. EUROPE COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 27. EUROPE COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 28. EUROPE COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 29. EUROPE COATED ENDOTRACHEAL TUBE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 30. GERMANY COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 31. GERMANY COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 32. GERMANY COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 33. FRANCE COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 34. FRANCE COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 35. FRANCE COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 36. UK COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 37. UK COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 38. UK COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 39. ITALY COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 40. ITALY COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 41. ITALY COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 42. SPAIN COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 43. SPAIN COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 44. SPAIN COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 45. REST OF EUROPE COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 46. REST OF EUROPE COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 47. REST OF EUROPE COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 48. ASIA-PACIFIC COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 49. ASIA-PACIFIC COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 50. ASIA-PACIFIC COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 51. ASIA-PACIFIC COATED ENDOTRACHEAL TUBE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 52. JAPAN COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 53. JAPAN COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 54. JAPAN COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 55. CHINA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 56. CHINA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 57. CHINA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 58. INDIA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 59. INDIA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 60. INDIA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 61. AUSTRALIA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 62. AUSTRALIA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 63. AUSTRALIA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 64. SOUTH KOREA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 65. SOUTH KOREA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 66. SOUTH KOREA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 70. LAMEA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 71. LAMEA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 72. LAMEA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 73. LAMEA COATED ENDOTRACHEAL TUBE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 74. BRAZIL COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 75. BRAZIL COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 76. BRAZIL COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 77. SAUDI ARABIA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 78. SAUDI ARABIA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 79. SAUDI ARABIA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 80. SOUTH AFRICA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 81. SOUTH AFRICA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 82. SOUTH AFRICA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 83. REST OF LAMEA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 84. REST OF LAMEA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 85. REST OF LAMEA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 86. BACTIGUARD: COMPANY SNAPSHOT
TABLE 87. BACTIGUARD: OPERATING SEGMENTS
TABLE 88. BACTIGUARD: PRODUCT PORTFOLIO
TABLE 89. AVANOS: COMPANY SNAPSHOT
TABLE 90. AVANOS: OPERATING SEGMENTS
TABLE 91. AVANOS: PRODUCT PORTFOLIO
TABLE 92. SMITHS MEDICAL: COMPANY SNAPSHOT
TABLE 93. SMITHS MEDICAL: OPERATING SEGMENTS
TABLE 94. SMITHS MEDICAL: PRODUCT PORTFOLIO
TABLE 95. HOSPITEK HEALTHCARE: COMPANY SNAPSHOT
TABLE 96. HOSPITEK HEALTHCARE: PRODUCT SEGMENTS
TABLE 97. HOSPITEK HEALTHCARE: PRODUCT PORTFOLIO
TABLE 01. MEDTRONIC: COMPANY SNAPSHOT
TABLE 02. MEDTRONIC: OPERATING BUSINESS SEGMENTS
TABLE 03. MEDTRONIC: PRODUCTS PORTFOLIO
TABLE 04. N8 MEDICAL LLC: COMPANY SNAPSHOT
TABLE 05. N8 MEDICAL LLC: PRODUCT SEGMENTS
TABLE 06. N8 MEDICAL: PRODUCTS PORTFOLIO
TABLE 07. SHARKLET TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 08. SHARKLET TECHNOLOGIES: PRODUCT SEGMENTS
TABLE 09. SHARKLET TECHNOLOGIES: PRODUCTS PORTFOLIO
TABLE 10. FUJI SYSTEMS: COMPANY SNAPSHOT
TABLE 11. FUJI SYSTEMS: PRODUCT SEGMENTS
TABLE 12. FUJI SYSTEMS: PRODUCTS PORTFOLIO
TABLE 13. TELEFLEX: COMPANY SNAPSHOT
TABLE 14. TELEFLEX: OPERATING SEGMENTS
TABLE 15. TELEFLEX: PRODUCT PORTFOLIO
TABLE 16. VENNER MEDICAL: COMPANY SNAPSHOT
TABLE 17. VENNER MEDICAL: PRODUCT SEGMENTS
TABLE 18. VENNER MEDICAL: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. TOP INVESTMENT POCKETS
FIGURE 02. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2017–2019(%)
FIGURE 03. TOP WINNING STRATEGIES: BY DEVELOPMENT, 2017-2019(%)
FIGURE 04. TOP WINNING STRATEGIES: BY COMPANY, 2017–2019 (%)
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE BARGAINING POWER OF BUYERS
FIGURE 07. MODERATE THREAT OF SUBSTITUTES
FIGURE 08. MODERATE THREAT OF NEW ENTRANTS
FIGURE 09. HIGH INTENSITY OF RIVALRY
FIGURE 10. TOP PLAYER POSITIONING, 2020
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF COATED ENDOTRACHEAL TUBE MARKET FOR OROTRACHEAL INTUBATION BY COUNTRY, 2020 & 2030 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF COATED ENDOTRACHEAL TUBE MARKET FOR NASOTRACHEAL INTUBATION BY COUNTRY, 2020 & 2030 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF COATED ENDOTRACHEAL TUBE MARKET FOR ANESTHESIA BY COUNTRY, 2020 & 2030 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF COATED ENDOTRACHEAL TUBE MARKET FOR EMERGENCY MEDICINE BY COUNTRY, 2020 & 2030 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF COATED ENDOTRACHEAL TUBE MARKET FOR OTHER APPLICATIONS BY COUNTRY, 2020 & 2030 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF COATED ENDOTRACHEAL TUBE MARKET FOR HOSPITALS BY COUNTRY, 2020 & 2030 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF COATED ENDOTRACHEAL TUBE MARKET FOR CLINICS BY COUNTRY, 2020 & 2030 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF COATED ENDOTRACHEAL TUBE MARKET FOR AMBULATORY SURGICAL CENTERS BY COUNTRY, 2020 & 2030 (%)
FIGURE 19. BACTIGUARD: NET SALES, 2018–2020 ($MILLION)
FIGURE 20. AVANOS: NET SALES, 2018–2020 ($MILLION)
FIGURE 21. AVANOS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 22. AVANOS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 23. SMITHS MEDICAL: NET SALES, 2018–2020 ($MILLION)
FIGURE 24.
FIGURE 25. SMITHS MEDICAL: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 26. SMITHS MEDICAL: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 01. MEDTRONIC: NET SALES, 2018–2020 ($MILLION
FIGURE 02. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 03. MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 04. TELEFLEX: NET SALES, 2018–2020 ($MILLION)
FIGURE 05. TELEFLEX: REVENUE SHARE BY BUSINESS SEGMENT, 2020 (%)
FIGURE 06. TELEFLEX: REVENUE SHARE BY GEOGRAPHY, 2020 (%)

Companies Mentioned

  • Bactiguard Holding AB
  • Avanos Medical
  • Hospiteknik Healthcare
  • Smiths Medical Plc.
  • Fuji Systems Corp.
  • N8 Medical LLC
  • Sharklet Technologies Inc.
  • Medtronic
  • Teleflex Incorporated
  • Venner Medical

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information